Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CVSA | Covista Inc. | 2026-09-17 14:59:55 | 126.49 | -0.86 | -0.68 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVSA | 0000730464 | Covista Inc. | US00737L1035 | 549300Z467EZLMODV621 | 363150143 | NYSE | 8200 | Services-Educational Services | 0630 | DE | 233 S. WACKER DRIVE | CHICAGO | IL | 60606 | UNITED STATES | US | 312-651-1400 | 233 S. WACKER DRIVE, CHICAGO, IL, 60606 | 233 S. WACKER DRIVE, CHICAGO, IL, 60606 | Adtalem Global Education Inc. | Education | 1973 | Stephen W. Beard | 10,000 | http://covista.com | 3,488,231,961 | 63,623,000 | 34,038,820 | Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University. | 2026-09-17 19:12:10 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2026 | 3,488,231,961 | 174,957,626 | 5.2805 | 34,038,820 | -1,916,892 | -5.3313 |
| 2025 | 3,313,274,335 | 1,035,494,910 | 45.4607 | 35,955,712 | -1,734,120 | -4.601 |
| 2024 | 2,277,779,425 | 697,942,663 | 44.1782 | 37,689,832 | -3,853,898 | -9.2767 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Douglas G. Beck | General Counsel, Senior Vice President, Corporate Secretary | 2025 | 535,806 | 0 | 536,406 | 457,428 | 122,207 | 1,651,847 |
| Michael Betz | President | 2025 | 648,092 | 250,000 | 689,150 | 896,610 | 111,049 | 2,594,901 |
| Stephen W. Beard | Chief Executive Officer, President | 2025 | 1,000,000 | 0 | 13,999,529 | 1,905,625 | 339,834 | 17,244,988 |
| Robert J. Phelan | Senior Vice President, Chief Financial Officer | 2025 | 540,268 | 0 | 948,817 | 501,696 | 24,546 | 2,015,327 |
| Scott Liles | President | 2025 | 537,500 | 0 | 671,180 | 376,212 | 34,806 | 1,619,698 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | 1,954,085,000 | 1,788,290,000 | 1,584,652,000 |
| Cost Of Revenue | 833,660,000 | 771,430,000 | 698,548,000 |
| Gross Profit | 1,120,425,000 | 1,016,860,000 | 886,104,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 730,720,000 | 672,004,000 | 632,965,000 |
| Operating Expenses | 1,570,709,000 | 1,446,748,000 | 1,367,598,000 |
| Operating Income | 383,376,000 | 341,542,000 | 217,054,000 |
| Net Income | 251,566,000 | 237,065,000 | 136,777,000 |
| Earnings Per Share Basic | 7.18 | 6.39 | 3.47 |
| Earnings Per Share Diluted | 7.04 | 6.18 | 3.39 |
| Weighted Average Shares Outstanding Basic | 35,045,000 | 37,085,000 | 39,413,000 |
| Weighted Average Shares Outstanding Diluted | 35,715,000 | 38,334,000 | 40,307,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 406,316,000 | 199,601,000 | 219,306,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 166,851,000 | 143,433,000 | 124,070,000 |
| Inventories | — | — | — |
| Non Trade Receivables | 2,710,000 | 2,756,000 | 2,763,000 |
| Other Assets Current | 75,126,000 | 68,837,000 | 70,050,000 |
| Total Assets Current | 652,441,000 | 416,190,000 | 418,085,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 302,649,000 | 256,131,000 | 248,524,000 |
| Other Assets Non Current | 137,738,000 | 129,145,000 | 103,184,000 |
| Total Assets Non Current | 507,013,000 | 447,325,000 | 433,104,000 |
| Total Assets | 3,012,708,000 | 2,752,352,000 | 2,741,417,000 |
| Accounts Payable | 124,763,000 | 105,017,000 | 102,626,000 |
| Deferred Revenue | 259,125,000 | 214,091,000 | 185,272,000 |
| Short Term Debt | 5,100,000 | 0 | 0 |
| Other Liabilities Current | 94,364,000 | 77,286,000 | 96,957,000 |
| Total Liabilities Current | 596,820,000 | 507,927,000 | 487,657,000 |
| Long Term Debt | 662,850,000 | 552,669,000 | 648,712,000 |
| Other Liabilities Non Current | 42,325,000 | 40,103,000 | 38,675,000 |
| Total Liabilities Non Current | 969,703,000 | 810,800,000 | 884,625,000 |
| Total Liabilities | 1,566,523,000 | 1,318,727,000 | 1,372,282,000 |
| Common Stock | 848,000 | 839,000 | 832,000 |
| Retained Earnings | 3,029,140,000 | 2,777,574,000 | 2,540,509,000 |
| Accumulated Other Comprehensive Income | -2,227,000 | -2,227,000 | -2,227,000 |
| Total Shareholders Equity | 1,446,185,000 | 1,433,625,000 | 1,369,135,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Depreciation And Amortization | 43,850,000 | 40,702,000 | 39,676,000 |
| Share Based Compensation Expense | 41,216,000 | 41,590,000 | 25,947,000 |
| Other Non Cash Income Expense | — | 0 | 0 |
| Change In Accounts Receivable | 89,263,000 | 80,820,000 | 76,355,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -8,423,000 | -5,546,000 | 8,781,000 |
| Change In Accounts Payable | 6,192,000 | 140,000 | 18,330,000 |
| Change In Other Liabilities | -9,697,000 | -15,948,000 | 27,422,000 |
| Cash From Operating Activities | 470,422,000 | 337,899,000 | 295,775,000 |
| Purchases Of Marketable Securities | 4,264,000 | 2,048,000 | 689,000 |
| Sales Of Marketable Securities | 3,260,000 | 3,120,000 | 1,732,000 |
| Acquisition Of Property Plant And Equipment | 77,696,000 | 50,327,000 | 48,893,000 |
| Acquisition Of Business | — | — | 0 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -83,700,000 | -41,921,000 | -47,850,000 |
| Tax Withholding For Share Based Compensation | 42,367,000 | 14,200,000 | 7,731,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 1,790,000 | 1,282,000 | 810,000 |
| Repurchase Of Common Stock | 239,866,000 | 213,125,000 | 261,966,000 |
| Issuance Of Long Term Debt | 1,007,450,000 | 9,873,000 | 1,896,000 |
| Repayment Of Long Term Debt | 895,283,000 | 109,873,000 | 51,896,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -180,132,000 | -316,016,000 | -301,798,000 |
| Change In Cash | 206,590,000 | -20,038,000 | -53,873,000 |
| Cash At End Of Period | 406,316,000 | 199,601,000 | 219,306,000 |
| Income Taxes Paid | 13,649,000 | 32,777,000 | 31,475,000 |
| Interest Paid | 44,841,000 | 46,596,000 | 57,842,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Earnings Per Share | 7.18 | 6.39 | 3.47 |
| Price To Earnings Ratio | 17.3621 | 19.9108 | 19.3862 |
| Earnings Growth Rate | 12.3631 | 84.1499 | 66.8269 |
| Price Earnings To Growth Ratio | 1.4044 | 0.2366 | 0.2901 |
| Book Value Per Share | 41.2665 | 38.6578 | 34.7382 |
| Price To Book Ratio | 3.0209 | 3.2912 | 1.9365 |
| Ebitda | 354,500,000 | 362,862,000 | 271,587,000 |
| Enterprise Value | 4,630,343,700 | 5,071,392,550 | 3,080,718,510 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.4619 | 0.3855 | 0.4738 |
| Capital Expenditures | 90,368,000 | 48,309,000 | 29,678,000 |
| Free Cash Flow | 380,054,000 | 289,590,000 | 266,097,000 |
| Return On Equity | 0.174 | 0.1654 | 0.0999 |
| One Year Beta | 0.2107 | 0.9199 | 0.7161 |
| Three Year Beta | 0.722 | 0.7544 | 0.6328 |
| Five Year Beta | 0.668 | 0.7411 | 0.7575 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| MALAFRONTE MICHAEL W | Director, Lead Independent Director | 2026-08-31 | 2,500 | D | 110,705 |
| Gangadharan Manjunath | VP, Chief Accounting Officer | 2026-08-27 | 1,802 | D | 5,083 |
| Beard, Stephen W. | Chairman & CEO | 2026-08-23 | 9,621 | D | 405,576 |
| Beard, Stephen W. | Chairman & CEO | 2026-08-23 | 53,144 | A | 458,720 |
| Beard, Stephen W. | Chairman & CEO | 2026-08-23 | 23,543 | D | 435,177 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| MERCER GLOBAL ADVISORS INC /ADV | 2026-06-30 | 1,005,632 | 8,067 | 124.66 |
| Fulcrum Asset Management LLP | 2026-06-30 | 3,963 | 32 | 123.8438 |
| Integrated Quantitative Investments LLC | 2026-06-30 | 1,354,182 | 10,863 | 124.66 |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-06-30 | 3,064,891 | 24,586 | 124.66 |
| Fieldview Capital Management, LLC | 2026-06-30 | 633,522 | 5,082 | 124.66 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| GLENMEDE FUND INC | 2026-07-31 | Disciplined U.S. Small Cap Equity Portfolio - Institutional Shares | GQSIX | 282 | 35,207.7 | 0.7973 |
| GLENMEDE FUND INC | 2026-07-31 | Disciplined U.S. Small Cap Equity Portfolio - Advisor Shares | GQSCX | 282 | 35,207.7 | 0.7973 |
| Vericimetry Funds | 2026-06-30 | Vericimetry U.S. Small Cap Value Fund | VYSVX | 1,660 | 206,935.6 | 0.1117 |
| JAMES ADVANTAGE FUNDS | 2026-06-30 | James Small Cap Fund | JASCX | 4,847 | 604,227.02 | 0.6573 |
| Advisor Managed Portfolios | 2026-06-30 | Optimize Strategy Index ETF | OPTZ | 6,258 | 780,122.28 | 0.2733 |